Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Clinical trial NCT00126490 · COMPLETED

Trial details

NCT number: NCT00126490
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Renal Cell Carcinoma Stage IV Renal Cell Cancer

Start date: 2005-03-01
Primary completion: 2012-06-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.